Elicio Therapeutics News

Elicio Therapeutics | 424B3: Prospectus

Nov 22 21:10

Elicio Therapeutics | EFFECT: Others

Nov 21 19:05

Elicio Therapeutics | 424B5: Prospectus

Jul 1 18:03

Elicio Therapeutics | 424B5: Prospectus

Jun 28 04:44

Elicio Therapeutics | EFFECT: Others

Jun 12 18:06

Elicio Therapeutics | EFFECT: Others

Jun 12 18:06

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 31, 2023 04:45

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 24, 2023 08:42

Angion Biomedica | EFFECT: Others

May 1, 2023 12:15

Angion Biomedica | 424B3: Prospectus

Apr 29, 2023 04:07

Angion Biomedica | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Apr 27, 2023 08:34

Angion Biomedica | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Apr 22, 2023 04:22

Angion Biomedica | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Apr 14, 2023 04:55

Angion Biomedica | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Mar 30, 2023 05:29

Angion Biomedica | S-4: Registration of securities issued in business combination transactions

Feb 14, 2023 06:26

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 19, 2023 05:47

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 19, 2023 05:44

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 19, 2023 05:42

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 17, 2023 19:09

Angion Biomedica | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 17, 2023 19:08